Business Context and Reporting Period
This Form 6-K filing is submitted by Galapagos NV, a foreign private issuer, for the month of June 2018. The filing, dated June 28, 2018, serves to incorporate by reference a press release (Exhibit 99.1) issued on the same date. The registrant is incorporated in Belgium and files annual reports on Form 20-F. Note: While the request metadata mentions "Lakefront Biotherapeutics NV," the filing text explicitly identifies the registrant as Galapagos NV.
Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This document is a procedural filing to distribute a press release and does not contain a financial statement or quarterly results summary.
Material Changes
The filing does not disclose material changes in financial position or operations compared to prior periods. It solely references the issuance of a press release on June 28, 2018, the content of which is attached as an exhibit but not detailed within the body of this Form 6-K text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It notes that the information in the attached press release (Exhibit 99.1) is incorporated by reference into various Registration Statements (Forms F-3 and S-8), but the specific content of that press release is not included in the provided text.
Key Facts for Investor Verification
- Verify the actual content of the press release dated June 28, 2018 (Exhibit 99.1), as the Form 6-K text only references it without summarizing its substance.
- Confirm the registrant identity is Galapagos NV, despite the metadata reference to Lakefront Biotherapeutics NV.
- Check the referenced Registration Statements (File Nos. 333-211765 and various S-8 filings) for the full context of the incorporated information.
- Note that no financial figures are available in this specific filing text.